Two-Photon Absorption Laser Induced Fluorescence Measurements of Neutral Density in Helicon Plasma

Neutral particles play a critical role in plasma experiments. They simultaneously act as a source of particles and a sink of momentum and energy. Also, they act as an intermediary between the plasma and surrounding material walls. However, few methods exist to make localized, direct neutral density measurements. A new diagnostic, based on two-photon absorption laser induced fluorescence (TALIF), capable of making direct ground state measurement is developed. A high intensity (5 MW/cm2), narrow bandwidth (0.1 cm -1) laser is used to directly probe the ground state of neutral hydrogen, deuterium and krypton. The diagnostic represents an improvement over traditional laser induced fluorescence in that it can be used to measure the spatial profile from a single porthole, and it can be operated in a Doppler-free configuration. The system is tested and calibrated in a low temperature helicon plasma source. Calculations show the system has sufficient performance to achieve an acceptable signal-to-noise ratio in a high temperature fusion plasma. Development of the diagnostic is presented in this work along with both steady-state and time-resolved TALIF measurements in helicon plasma

changeRangeR: An R package for reproducible biodiversity change metrics from species distribution estimates

Conservation planning and decision-making rely on evaluations of biodiversity status and threats that are based upon species' distribution estimates. However, gaps exist regarding automated tools to delineate species' current ranges from distribution estimates and use those estimates to calculate both species- and community-level biodiversity metrics. Here, we introduce changeRangeR, an R package that facilitates workflows to reproducibly transform estimates of species' distributions into metrics relevant for conservation. For example, by combining predictions from species distribution models (SDMs) with other maps of environmental data (e.g., suitable forest cover), researchers can characterize the proportion of a species' range that is under protection, metrics used under the IUCN Criteria A and B guidelines (Area of Occupancy and Extent of Occurrence), and other more general metrics such as taxonomic and phylogenetic diversity and endemism. Further, changeRangeR facilitates temporal comparisons among biodiversity metrics to inform efforts toward complementarity and consideration of future scenarios in conservation decisions. changeRangeR also provides tools to determine the effects of modeling decisions through sensitivity tests. Transparent and repeatable workflows for calculating biodiversity change metrics from SDMs such as those provided by changeRangeR are essential to inform conservation decision-making efforts and represent key extensions for SDM methodology and associated metadata documentation.journal articl

wallace 2: a shiny app for modeling species niches and distributions redesigned to facilitate expansion via module contributions

Released 4 years ago, the Wallace EcoMod application (R package wallace) provided an open-source and interactive platform for modeling species niches and distributions that served as a reproducible toolbox and educational resource. wallace harnesses R package tools documented in the literature and makes them available via a graphical user interface that runs analyses and returns code to document and reproduce them. Since its release, feedback from users and partners helped identify key areas for advancement, leading to the development of wallace 2. Following the vision of growth by community expansion, the core development team engaged with collaborators and undertook a major restructuring of the application to enable: simplified addition of custom modules to expand methodological options, analyses for multiple species in the same session, improved metadata features, new database connections, and saving/loading sessions. wallace 2 features nine new modules and added functionalities that facilitate data acquisition from climate-simulation, botanical and paleontological databases; custom data inputs; model metadata tracking; and citations for R packages used (to promote documentation and give credit to developers). Three of these modules compose a new component for environmental space analyses (e.g., niche overlap). This expansion was paired with outreach to the biogeography and biodiversity communities, including international presentations and workshops that take advantage of the software's extensive guidance text. Additionally, the advances extend accessibility with a cloud-computing implementation and include a suite of comprehensive unit tests. The features in wallace 2 greatly improve its expandability, breadth of analyses, and reproducibility options, including the use of emerging metadata standards. The new architecture serves as an example for other modular software, especially those developed using the rapidly proliferating R package shiny, by showcasing straightforward module ingestion and unit testing. Importantly, wallace 2 sets the stage for future expansions, including those enabling biodiversity estimation and threat assessments for conservation.journal articl

Acute mesenteric ischemia : updated guidelines of the World Society of Emergency Surgery

Acute mesenteric ischemia (AMI) is a group of diseases characterized by an interruption of the blood supply to varying portions of the intestine, leading to ischemia and secondary inflammatory changes. If untreated, this process may progress to life-threatening intestinal necrosis. The incidence is low, estimated at 0.09-0.2% of all acute surgical admissions, but increases with age. Although the entity is an uncommon cause of abdominal pain, diligence is required because if untreated, mortality remains in the range of 50%. Early diagnosis and timely surgical intervention are the cornerstones of modern treatment to reduce the high mortality associated with this entity. The advent of endovascular approaches in parallel with modern imaging techniques is evolving and provides new treatment options. Lastly, a focused multidisciplinary approach based on early diagnosis and individualized treatment is essential. Thus, we believe that updated guidelines from World Society of Emergency Surgery are warranted, in order to provide the most recent and practical recommendations for diagnosis and treatment of AMI.Peer reviewe

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

changeRangeR: An R package for reproducible biodiversity change metrics from species distribution estimates

Abstract Conservation planning and decision‐making rely on evaluations of biodiversity status and threats that are based upon species' distribution estimates. However, gaps exist regarding automated tools to delineate species' current ranges from distribution estimates and use those estimates to calculate both species‐ and community‐level biodiversity metrics. Here, we introduce changeRangeR, an R package that facilitates workflows to reproducibly transform estimates of species' distributions into metrics relevant for conservation. For example, by combining predictions from species distribution models (SDMs) with other maps of environmental data (e.g., suitable forest cover), researchers can characterize the proportion of a species' range that is under protection, metrics used under the IUCN Criteria A and B guidelines (Area of Occupancy and Extent of Occurrence), and other more general metrics such as taxonomic and phylogenetic diversity and endemism. Further, changeRangeR facilitates temporal comparisons among biodiversity metrics to inform efforts toward complementarity and consideration of future scenarios in conservation decisions. changeRangeR also provides tools to determine the effects of modeling decisions through sensitivity tests. Transparent and repeatable workflows for calculating biodiversity change metrics from SDMs such as those provided by changeRangeR are essential to inform conservation decision‐making efforts and represent key extensions for SDM methodology and associated metadata documentation

Operationalizing expert knowledge in species' range estimates using diverse data types

Estimates of species’ ranges can inform many aspects of biodiversity research and conservation-management decisions. Many practical applications need high-precision range estimates that are sufficiently reliable to use as input data in downstream applications. One solution has involved expert-generated maps that reflect on-the-ground field information and implicitly capture various processes that may limit a species’ geographic distribution. However, expert maps are often subjective and rarely reproducible. In contrast, species distribution models (SDMs) typically have finer resolution and are reproducible because of explicit links to data. Yet, SDMs can have higher uncertainty when data are sparse, which is an issue for most species. Also, SDMs often capture only a subset of the factors that determine species distributions (e.g., climate) and hence can require significant post-processing to better estimate species’ current realized distributions. Here, we demonstrate how expert knowledge, diverse data types, and SDMs can be used together in a transparent and reproducible modeling workflow. Specifically, we show how expert knowledge regarding species’ habitat use, elevation, biotic interactions, and environmental tolerances can be used to make and refine range estimates using SDMs and various data sources, including high-resolution remotely sensed products. This range-refinement approach is primed to use various data sources, including many with continuously improving spatial or temporal resolution. To facilitate such analyses, we compile a comprehensive suite of tools in a new R package, maskRangeR, and provide worked examples. These tools can facilitate a wide variety of basic and applied research that requires high-resolution maps of species’ current ranges, including quantifications of biodiversity and its change over time